Processing Your Payment

Please do not leave this page until complete. This can take a few moments.

May 29, 2024

After two-year hiatus, Agwunobi will return as UConn Health CEO

Paul Horton/UConn Photo Dr. Andrew Agwunobi

After two years as president of Home Solutions for health insurer Humana, Dr. Andrew Agwunobi will return to UConn Health to serve as its CEO and executive vice president of health affairs.

Agwunobi previously had a dual role of interim president of the University of Connecticut and CEO of UConn Health. He left to work for Humana in early 2022, after starting with Uconn Health in 2014.

Agwunobi was selected after an extensive national search.

During his previous eight-year tenure, Agwunobi was known for doubling patient net revenues and overseeing an $800 million campus infrastructure project at UConn Health.

Gov. Ned Lamont said Agwunobi helped raise UConn Health’s reputation as a national leader.

“UConn Health is one of the most highly regarded academic medical centers in the country, and I want to grow its standing as an international hub of innovation where advancements and cutting-edge research are being made,” Lamont said.

UConn President Radenka Maric said she’s “thrilled” that Agwunobi will return “to lead the next phase of transformation.”

“Andy’s extensive experience leading complex academic, and private health systems, serving as a senior healthcare consultant, and working in the payer industry, combined with his deep knowledge of UConn Health and the broader university make him the perfect leader to take UConn Health to the next level,” Maric said. 

UConn Health has been working toward generating more of its own revenue, reducing its dependency on state funding.

Between 2014 and 2024, clinical care revenue generated by UConn Health rose by 154%, from $371.5 million in 2014 to $944 million. 

Self-generated revenue accounts for 60% of the current budget, with the state contributing 13% in the next fiscal year – down from 27% in 2014.

Agwunobi is a pediatrician with an MBA from Stanford Business School.

He will begin at UConn Health on May 31.

“I am honored to return to an organization that I deeply care for,” Agwunobi said. “I believe strongly in UConn Health and its tripartite mission of research, education and clinical care, and I am excited to work with stakeholders at UConn Health, the university and the state to advance UConn Health to the next level of excellence including academic stature, scale, partnerships, innovation and financial strength.”

Dr. Bruce Liang, who was named interim CEO of UConn Health after Agwunobi’s 2022 departure, will continue as its dean of the School of Medicine.

Sign up for Enews


Order a PDF